Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramosetron and Naloxone for PONV after Gynecologic Surgery
NCT02416115Completed
- Sponsor
- Kyungpook National University Hospital
- Start
- Jul 2014
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
01
Overview
Randomised, double-blind trial of ramosetron and naloxone in postoperative nausea and vomiting (PONV), sponsored by Kyungpook National University Hospital. Primary endpoint: Incidence of postoperative nausea and vomiting at 24 hours. Started Jul 2014; status: completed.
02
Drugs
ramosetronnaloxone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02416115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02416115.